Identification and management of women at high risk for pelvic infection following cesarean section.
D000038:Abscess / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002435:Cefamandole / Q000627:therapeutic use; D002585:Cesarean Section; D004359:Drug Therapy, Combination; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D010249:Parametritis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011300:Preoperative Care; D011645:Puerperal Infection / Q000188:drug therapy / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D002435:Cefamandole